Cartesian Therapeutics
RNAC
#7439
Rank
โ‚ฌ0.28 B
Marketcap
10,69ย โ‚ฌ
Share price
3.21%
Change (1 day)
-48.01%
Change (1 year)

Earnings for Cartesian Therapeutics (RNAC)

Earnings in 2024 (TTM): -โ‚ฌ70.94 Million

According to Cartesian Therapeutics's latest financial reports the company's current earnings are โ‚ฌ38.91 Million. , an increase over its 2023 earnings that were of -โ‚ฌ0.21 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cartesian Therapeutics from 2015 to 2024

Annual earnings

Year Earnings Change
2024 -โ‚ฌ67.52 Million-67.3%
2023 -โ‚ฌ0.21 Billion-724%
2022 โ‚ฌ33.08 M-649.67%
2021 -โ‚ฌ6.02 Million-89.78%
2020 -โ‚ฌ58.92 Million25.06%
2019 -โ‚ฌ47.12 Million-15.68%
2018 -โ‚ฌ55.88 Million-0.43%
2017 -โ‚ฌ56.12 Million83.41%
2016 -โ‚ฌ30.6 Million44.3%
2015 -โ‚ฌ21.21 Million